Searched over 200M research papers
10 papers analyzed
These studies suggest that genetic factors, including specific genetic variations and hereditary disorders, can influence stroke risk.
14 papers analyzed
20 papers analyzed
Monogenic disorders, which are caused by mutations in a single gene, account for a small percentage of stroke cases, estimated at about 1% to 5% . Some of the most well-known monogenic disorders associated with stroke include CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy), CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy), Fabry disease, and MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) . These conditions often lead to early-onset strokes and have distinct clinical features that can aid in diagnosis and management.
The majority of strokes are polygenic, meaning they result from the combined effect of multiple genes, each contributing a small amount to the overall risk . Genome-wide association studies (GWAS) have identified numerous genetic loci associated with stroke risk, highlighting the complex interplay of genetic factors in stroke pathogenesis . For instance, variations in genes involved in lipid metabolism, thrombosis, and inflammation have been implicated in increasing stroke susceptibility .
Genetic variations can influence the risk of different types of stroke, including ischemic and hemorrhagic strokes. Specific single nucleotide polymorphisms (SNPs) have been linked to subtypes of ischemic stroke, such as large vessel disease and cardioembolism, as well as to particular forms of intracerebral hemorrhage (ICH) . These genetic markers can help in understanding individual susceptibility and tailoring preventive strategies.
Certain genetic factors also predispose individuals to conditions that increase stroke risk, such as atrial fibrillation, hypertension, and white matter hyperintensities . These conditions often have a hereditary component, further complicating the genetic landscape of stroke.
Recent advancements in genetic research have expanded our understanding of the mechanisms underlying stroke. Approximately 35 genetic loci have been linked to stroke risk, revealing novel pathways related to large artery atherosclerosis, cardioembolism, and small vessel disease. These discoveries are crucial for developing targeted therapies and improving stroke prevention strategies.
Genetic factors also play a role in stroke recovery and response to treatment. For example, genetic variations can influence the efficacy and safety of tissue plasminogen activator (tPA), a common treatment for acute ischemic stroke. Understanding these genetic influences can help optimize treatment plans and improve patient outcomes.
In summary, stroke has a significant hereditary component, influenced by both monogenic and polygenic factors. While monogenic disorders account for a small percentage of stroke cases, polygenic influences are more common and involve complex interactions between multiple genes. Advances in genetic research are shedding light on the mechanisms of stroke, offering new avenues for prevention, diagnosis, and treatment. Understanding the genetic basis of stroke is essential for developing personalized medicine approaches and improving outcomes for patients at risk.
Most relevant research papers on this topic